about
Inhibition of growth in medullary thyroid cancer cells with histone deacetylase inhibitors and lithium chloride.Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cellsInhibition of the PI3K pathway suppresses hormonal secretion and limits growth in pheochromocytoma cells.Older age and larger tumor size predict malignancy in hürthle cell neoplasms of the thyroid.Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer?Histone deacetylase inhibitors upregulate Notch-1 and inhibit growth in pheochromocytoma cellsTautomycin suppresses growth and neuroendocrine hormone markers in carcinoid cells through activation of the Raf-1 pathwayTautomycetin and tautomycin suppress the growth of medullary thyroid cancer cells via inhibition of glycogen synthase kinase-3beta.Pheochromocytoma: current approaches and future directions.Preserving function and quality of life after thyroid and parathyroid surgery.Combination therapy with histone deacetylase inhibitors and lithium chloride: a novel treatment for carcinoid tumors.New trends in parathyroid surgery.Renal allograft thrombosis after living donor transplantation: risk factors and obstacles to retransplantation.Seasonal Variation in Diverticulitis: Evidence From Both Hemispheres.How Far Are Patients Willing to Travel for Gastrectomy?Is Donor Service Area Market Competition Associated With Organ Procurement Organization Performance?Distance is associated with mortality on the waitlist in pediatric liver transplantation.Market Competition and Density in Liver Transplantation: Relationship to Volume and Outcomes.Role of Patient Factors and Practice Patterns in Determining Access to Liver Waitlist.Temporal Analysis of Market Competition and Density in Renal Transplantation Volume and Outcome.Identification of Race and Ethnicity in Large Databases.Isolated adrenal mass in patients with a history of cancer: remember pheochromocytoma.Does routine use of ultrasound result in additional thyroid procedures in patients with primary hyperparathyroidism?Market competition influences renal transplantation risk and outcomes.The influence of surgical approach on quality of life after parathyroid surgery.Revisiting adrenal mass size as an indication for adrenalectomy.Pediatric kidney transplantation and mortality: Distance to transplant center matters.Comparing Preoperative Targets to Failure-to-Rescue for Surgical Mortality Improvement.Socioeconomic gradients between locally transplanted and exported liver donors and recipients.Socioeconomic status and ethnicity of deceased donor kidney recipients compared to their donors.Parathyroidectomy for primary hyperparathyroidism in octogenarians and nonagenarians: a risk-benefit analysis.Surgery improves quality of life in patients with "mild" hyperparathyroidism.Social determinants in liver transplantationWhat is the Added Benefit of Cervical Ultrasound to 99mTc-Sestamibi Scanning in Primary Hyperparathyroidism?25-Hydroxyvitamin D Status Does Not Affect Intraoperative Parathyroid Hormone Dynamics in Patients with Primary HyperparathyroidismPrinciples of Minimally Invasive ParathyroidectomyEqual Oncologic Results for Laparoscopic and Open Resection of Adrenal MetastasesEnteric conversion after bladder-drained pancreas transplantation is not associated with worse allograft survival.Do Social Determinants Define "Too Sick" to Transplant in Patients With End-stage Liver Disease?Isolated pancreas transplantation: Is rank list position related to outcomes of imported grafts?
P50
Q33804934-C93B6841-F4E6-46FF-8F60-CF72A8696726Q33998266-46FFEAB5-FEC0-462F-9FA8-34BD27589A81Q34939579-E1496569-EAEC-40B6-B58C-67C1CEC1A6D6Q36856804-63C49C34-6636-47F9-B827-4F1F6A5A20BCQ36953799-C1224AAF-74CC-4F20-A632-4ECCD370D518Q37089077-420DEAB3-8E27-43C6-A49E-7D61370CAB69Q37148789-BA6DF209-8050-48E4-8DA8-F0000B12E7B1Q37161813-399AC646-6A9C-4DC6-BF2C-50853B9C72B8Q37212647-37600CA1-BF59-487C-BF25-C54E96327131Q37326835-A461BC2F-B5E4-41DA-A8DA-564DF2032E73Q37339815-FD499262-65B0-4B91-8244-875564828EADQ37806412-63E033E5-1817-40AE-96BE-32DE7E373E6BQ38878100-5E8A4345-7611-477A-B652-3E4AF6587EE5Q39508116-318232A1-CBF9-4D30-888C-78E6668A0FC1Q39697162-7730E066-4691-4D95-8DA4-3149970434FEQ40376005-CA526D4E-EC2F-4BA6-8497-D3F03E70CA55Q40497166-CFA771A1-E0E8-4AE8-B828-95C3915A3BD4Q40701216-BDEC3787-F54D-44DF-8D72-18EBD6543947Q40990166-497362E2-9266-4E10-828C-A17A296AE776Q41119799-42CE91B8-631D-4FC4-97A4-8692F222BBAAQ43954167-2B81EDD6-C253-463F-8CD3-1616E8D2E266Q44099674-76AE64EC-F0D5-4DEA-ACCA-C7E607E4A816Q45048374-6560E8D0-E509-4A6A-93AA-16861BB2D3A1Q46504543-C587D9F3-063C-4685-A687-16157CFFE785Q46596674-A6DA4656-3FD2-47A4-A5B7-BF43B23D445CQ47177244-7C9206CA-DBF8-44D1-849B-3FF44DE62BE7Q47189029-EAE990D0-7C2F-4980-A074-67DC802C4692Q47981414-F01D3847-602B-46F3-BE1E-E5B872E366FBQ50235811-BD640F85-0B69-4124-88A1-8FFE09DACD76Q50949981-219D7115-AEE1-456B-8550-8219DCBC5DE2Q51903560-FC6E909D-ECD7-4AD6-9B8A-DD68AE20A3BEQ53113392-6545EB85-3E26-4ED7-ABE6-342B053E7ADFQ57817617-CAEE091C-FBC9-4747-A71A-91F5CAF7105AQ57817645-20D8F88F-142E-4ECB-B6B3-8EED18093019Q57817651-0C8B9C19-07F6-433B-A7A9-A06150454F19Q57817693-7DA8950E-E051-416B-8061-348D496BE9FBQ57817699-0CB0014F-D081-4B7B-9906-0B1F215914D8Q64979208-E491D2DD-A865-401B-AFC1-DD59907D6956Q92120888-7D6E2277-AE79-4B8F-A7F1-CBCB3886BCA7Q92962289-0933C2A4-6E9E-4926-A92F-B2D13261721D
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Joel T Adler
@nl
Joel T Adler
@sl
Joel T. Adler
@en
Joel T. Adler
@es
type
label
Joel T Adler
@nl
Joel T Adler
@sl
Joel T. Adler
@en
Joel T. Adler
@es
prefLabel
Joel T Adler
@nl
Joel T Adler
@sl
Joel T. Adler
@en
Joel T. Adler
@es
P106
P1153
16303282100
57190808980
P21
P31
P496
0000-0001-8190-3444